ClinicalTrials.gov
public full text
Public Domain
Dose Range Finding Study of Fedovapagon in Men With Nocturia
The purpose of this study is to determine the dose level(s) of fedovapagon which result in a decrease in the mean nocturnal void frequency.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial#894730
- Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study#980938
- A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men#901421
- A Study Testing the Effects of Different THC Doses on Psychological and Biological Function#1044401
- Treatment of Patients With Nocturia#911322
Record · ID 1096974
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive